Reliance Operating Cash Flow decreased by 45.2% to $151.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 134.7%, from $64.50M to $151.40M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a 1.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $101.60M | $142.20M | $393.80M | $404.00M | $270.20M | $635.70M | $808.70M | $384.60M | $295.10M | $466.00M | $525.60M | $126.30M | $366.30M | $463.90M | $473.30M | $64.50M | $229.00M | $261.80M | $276.10M | $151.40M |
| QoQ Change | — | +40.0% | +176.9% | +2.6% | -33.1% | +135.3% | +27.2% | -52.4% | -23.3% | +57.9% | +12.8% | -76.0% | +190.0% | +26.6% | +2.0% | -86.4% | +255.0% | +14.3% | +5.5% | -45.2% |
| YoY Change | — | — | — | — | +165.9% | +347.0% | +105.4% | -4.8% | +9.2% | -26.7% | -35.0% | -67.2% | +24.1% | -0.5% | -10.0% | -48.9% | -37.5% | -43.6% | -41.7% | +134.7% |